San Francisco Department of Public Health Low Barrier Buprenorphine Pilot Program
These are slides from a 2019 presentation on the results of a low barrier buprenorphine pilot program conducted by the San Francisco Department of Public Health.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
These are slides from a 2019 presentation on the results of a low barrier buprenorphine pilot program conducted by the San Francisco Department of Public Health.
Assesses substance use disorder (SUD) risk among adolescents 12-17 years old.
Supports face-to-face training to review results from research conducted by the NIDA CTN comparing detoxification with buprenorphine versus clonidine. Provides instruction for implementing this protocol in treatment settings, including methods of evaluation and induction, the taper schedule, and use of ancillary medications during treatment.
Guides physicians to incorporate screening, brief interventions, and referrals to treatment for use of alcohol, tobacco, marijuana, and other drugs among adolescent patients.
Provides resources for practitioners who supervise peer workers.